Gene · 107
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Current Treatments and New, Tentative Therapies for Parkinson's Disease. | Pharmaceutics | 2023 | 36986631 | PubTator, text mining | PubMed |
| Plant-Based Antioxidants for Prevention and Treatment of Neurodegenerative Diseases: Phytotherapeutic Potential of Laurus nobilis, Aronia melanocarpa, and Celastrol. | Antioxidants (Basel) | 2023 | 36978994 | PubTator, text mining | PubMed |
| The CLDN5 gene at the blood-brain barrier in health and disease. | Fluids Barriers CNS | 2023 | 36978081 | PubTator, text mining | PubMed |
| Clinical Benefit of Autologous Platelet-Rich Plasma Infusion in Ovarian Function Rejuvenation: Evidence from a Before-After Prospective Pilot Study. | Medicines (Basel) | 2023 | 36976308 | PubTator, text mining | PubMed |
| A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer. | Front Oncol | 2023 | 36969015 | PubTator, text mining | PubMed |
| Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers. | iScience | 2023 | 36968082 | PubTator, text mining | PubMed |
| Prolactin and oxytocin: potential targets for migraine treatment. | J Headache Pain | 2023 | 36967387 | PubTator, text mining | PubMed |
| MiR-1281 is involved in depression disorder and the antidepressant effects of Kai-Xin-San by targeting ADCY1 and DVL1. | Heliyon | 2023 | 36938448 | PubTator, text mining | PubMed |
| Serum lipid profile of stroke patients attending at Dessie comprehensive specialized hospital, Dessie, Northeast Ethiopia: A comparative cross-sectional study. | Heliyon | 2023 | 36938383 | PubTator, text mining | PubMed |
| Infant With Pseudohypoparathyroidism Type 1a, Misdiagnosed as Congenital Hypothyroidism. | Med Arch | 2023 | 36923733 | PubTator, text mining | PubMed |
| Downregulated INHBB in endometrial tissue of recurrent implantation failure patients impeded decidualization through the ADCY1/cAMP signalling pathway. | J Assist Reprod Genet | 2023 | 36913138 | PubTator, text mining | PubMed |
| Health-Promoting Properties and Potential Application in the Food Industry of Citrus medica L. and Citrus × clementina Hort. Ex Tan. Essential Oils and Their Main Constituents. | Plants (Basel) | 2023 | 36903853 | PubTator, text mining | PubMed |
| Molecular basis of skin photoaging and therapeutic interventions by plant-derived natural product ingredients: A comprehensive review. | Heliyon | 2023 | 36895391 | PubTator, text mining | PubMed |
| MiR-760 targets HBEGF to control cartilage extracellular matrix degradation in osteoarthritis. | J Orthop Surg Res | 2023 | 36894989 | PubTator, text mining | PubMed |
| Identification of protein candidates in spermatozoa of water buffalo (Bubalus bubalis) bulls helps in predicting their fertility status. | Front Cell Dev Biol | 2023 | 36891514 | PubTator, text mining | PubMed |
| SLC26A9 in airways and intestine: secretion or absorption? | Channels (Austin) | 2023 | 36866602 | PubTator, text mining | PubMed |
| PIMT regulates hepatic gluconeogenesis in mice. | iScience | 2023 | 36866247 | PubTator, text mining | PubMed |
| EPAC1 Pharmacological Inhibition with AM-001 Prevents SARS-CoV-2 and Influenza A Virus Replication in Cells. | Viruses | 2023 | 36851533 | PubTator, text mining | PubMed |
| Establishing a Prediction Model for the Efficacy of Platinum-Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study. | J Clin Med | 2023 | 36835855 | PubTator, text mining | PubMed |
| First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry. | Int J Mol Sci | 2023 | 36835058 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/107/papers?page=11